Related Experiment Video
Updated: May 23, 2026

07:41
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
Molecular networks that regulate cancer metastasis
Daniela Spano1, Chantal Heck, Pasqualino De Antonellis
1CEINGE, Biotecnologie Avanzate, Naples, Italy.
Seminars in Cancer Biology
|April 10, 2012
Summary
Metastasis drives most cancer deaths. Understanding the genetic events and molecular networks promoting cancer cell invasion and spread is key to developing new treatments targeting these processes.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Tumor metastases are a primary cause of cancer mortality, accounting for approximately 90% of cancer-related deaths.
- Despite advances, cancer remains a leading cause of death globally, underscoring the need for effective therapeutic strategies.
- Recent genomic discoveries have significantly advanced our understanding of the molecular mechanisms underlying cancer metastasis.
Purpose of the Study:
- To elucidate the genetic events and critical factors that define the metastatic phenotype during tumorigenesis.
- To explore the molecular networks involved in various stages of metastasis, from local invasion to distant outgrowth.
- To identify candidate target proteins and signaling pathways for novel anti-metastatic therapies.
Main Methods:
- Review and synthesis of recent discoveries in cancer genomics and metastasis research.
- Analysis of molecular networks facilitating cancer cell invasion, intravasation, and extravasation.
- Identification of key factors involved in the formation of the metastatic microenvironment and metastatic outgrowth.
Main Results:
- Detailed delineation of molecular networks promoting local invasion, single-cell invasion, and intravasation.
- Characterization of processes involved in lymphogenic and hematogenous metastasis, including extravasation.
- Identification of molecular networks that foster metastatic outgrowth in distant organs.
- Identification of candidate proteins and signaling pathways currently under clinical investigation for metastatic cancer treatment.
Conclusions:
- The metastatic phenotype is driven by complex genetic events and molecular networks.
- Targeting these specific molecular networks and proteins offers a promising avenue for developing new treatments for metastatic cancers.
- Ongoing clinical trials targeting these pathways provide a basis for future therapeutic advancements in managing metastatic disease.
Related Concept Videos
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Protein Networks
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Non-Canonical Wnt Signaling Pathways
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

